JUL 29, 2020 3:25 AM PDT

Regulating Apoptosis in Prostate Cancer

WRITTEN BY: Jasper Cantrell

Cancer treatments tend to work in one of a few ways. They can target the immune system, prevent cancer proliferation and metastasis, or induce a cell death pathway. Any of these alone can work against cancer, and some even work better in combination.

A team from the Virginia Common Wealth University wanted to investigate how a new finding in the FOXO1 apoptosis pathway, a cell death pathway, would affect prostate cancer. The FOXO proteins are a family of transcription factors responsible for regulating the expression of certain genes. FOXO1, in particular, controls several pro-apoptosis genes.

This new study built off of previous work that had identified an essential cell cycle regulator, PLK1, as a regulator of FOXO1. PLK1 phosphorylates FOXO1 and prevents its transportation into the nucleus.  Without FOXO1 in the nucleus, the cells apoptotic pathways were silenced. It could even cause increased cancer growth.

The team wanted to see if these findings they saw before were the same in prostate cancer cells. They used FOXO1 mutants that mimicked the phosphorylated and unphosphorylated states to investigate. Like in their previous work, the phosphorylated mimic prevented expression FOXO1 pro-apoptotic genes, and the unphosphorylated mimic correctly localized to the nucleus.

They then wanted to test if they could inhibit PLK1 and prevent the phosphorylation of FOXO1. They used a PLK1 inhibitor in prostate cancer cells and found that it increased FOXO1 in the nucleus, and even induced FOXO1 apoptotic pathways. All signs of a potential anti-cancer drug.

The team then wanted to investigate if the PLK1 inhibitor might be able to work in combination with another anti-cancer drug, nocodazole. Both drugs caused adverse side effects in clinical trials, but together the team hoped they could reduce the dosage and still elicit a strong anti-cancer effect. 

Using prostate cancer cells, they indeed saw a stronger anti-cancer effect with the combination treatment compared to either alone. They even saw signs that the combination did not elicit any harmful side effects when tested in healthy prostate cells.

This study identifies PLK1 inhibitors as potential anti-cancer drugs for prostate cancer. In combination with another compound, nocodazole, it could elicit even stronger anti-cancer activities with no apparent side effects.

The team concluded, “These findings shed light on a novel approach to reactivate apoptotic pathways in advanced PCa and support targeting PLK1-FOXO1 pathways as a novel therapeutic approach for treating advanced PCa.”

Sources: Nature Scientific Reports, Walter Jahn

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
JUL 15, 2020
Immunology
Immune Memory to Thwart Recurring Cancer
JUL 15, 2020
Immune Memory to Thwart Recurring Cancer
Preventing cancer from returning in the body is an integral part of any anti-cancer treatment plan. New discoveries from ...
AUG 16, 2020
Cancer
Cancer mapping shows health disparities in remote areas
AUG 16, 2020
Cancer mapping shows health disparities in remote areas
Scientists mapping cancer statistics have developed a new mathematical model to track health inequalities relating to th ...
AUG 20, 2020
Cancer
Should you trust a robot to perform your cancer surgery?
AUG 20, 2020
Should you trust a robot to perform your cancer surgery?
How would you feel about a robot conducting your cancer surgery? According to new research published in JAMA Oncology, i ...
AUG 21, 2020
Immunology
Cancer Feels the STING
AUG 21, 2020
Cancer Feels the STING
Researchers have discovered a protein that can amplify immune reactions against tumors. The stimulator of interferon gen ...
AUG 24, 2020
Cancer
Inhibiting Cancer Stem Cells to Stop Cancer Recurrence
AUG 24, 2020
Inhibiting Cancer Stem Cells to Stop Cancer Recurrence
Once upon a time, stem cells were the talk of the town. They really are amazing, with some capable of turning into any o ...
SEP 04, 2020
Cancer
Attacking Cancer's Metabolism: A New Take on Fermented Wheat Germ Extract
SEP 04, 2020
Attacking Cancer's Metabolism: A New Take on Fermented Wheat Germ Extract
One of the hallmarks of evolution is the oxidative phosphorylation metabolic system. Not only does it produce energy in ...
Loading Comments...